XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.2

Note 10 - Segment and Geographic Data (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Three Months ending June 30, 2025
		Corporate				Dental				Medical				Grand Total
Product sales, net			-				2,291,366				32,100				2,323,466
Cost of products sold			-				704,866				994				705,860
Gross Margin			-				1,586,500				31,106				1,617,606
Salaries & employee benefits			206,777				440,463				192,733				839,973
Stock-based compensation expense			159,678				-				-				159,678
Royalty expense			-				118,174				1,605				119,779
Marketing			10,156				48,047				19,907				78,110
Rent & occupancy costs			21,703				13,852				8,657				44,212
Consultants and professional services fees			698,388				83,134				119,069				900,591
Insurance			40,503				45,225				40,078				125,806
Warehousing expense			5,033				106,685				17,188				128,906
Regulatory expense			263,931				66,144				3,087				333,162
Travel expense			12,005				25,870				35,330				73,205
Research and development expense			-				47,089				4,700				51,789
Depreciation and amortization expense			19,496				-				-				19,496
Other segment items			79,433				136,193				11,904				227,530
Total operating expenses			1,517,103				1,130,876				454,258				3,102,237

Operating income (loss) (1,517,103 ) 455,624 (423,152 ) (1,484,631 )

		Three Months ending June 30, 2024
		Corporate				Dental				Medical				Grand Total
Product sales, net			-				1,834,764				19,000				1,853,764
Cost of products sold			-				442,659				(99	)			442,560
Gross Margin			-				1,392,105				19,099				1,411,204
Salaries & employee benefits			307,416				344,828				195,922				848,166
Stock-based compensation expense			207,688				-				-				207,688
Royalty expense			-				94,000				950				94,950
Marketing			20,144				140,446				9,400				169,990
Rent & occupancy costs			25,087				12,243				7,652				44,982
Consultants and professional services fees			485,328				1,354				267,114				753,796
Insurance			127,909				-				3,661				131,570
Warehousing expense			3,615				120,794				14,978				139,387
Regulatory expense			140,295				(913	)			6,332				145,714
Travel expense			6,733				41,237				24,204				72,174
Research and development expense			-				314,968				-				314,968
Depreciation and amortization expense			8,477				-				-				8,477
Other segment items			154,095				103,704				1,966				259,765
Total operating expenses			1,486,787				1,172,661				532,179				3,191,627
Operating income (loss)			(1,486,787	)			219,444				(513,080	)			(1,780,423	)

		Six Months ending June 30, 2025
		Corporate				Dental				Medical				Grand Total
Product sales, net			-				4,472,536				83,350				4,555,886
Cost of products sold			-				1,289,761				1,084				1,290,845
Gross Margin			-				3,182,775				82,266				3,265,041
Salaries & employee benefits			323,885				881,961				398,847				1,604,693
Stock-based compensation expense			490,466				-				-				490,466
Royalty expense			-				228,102				4,168				232,270
Marketing			14,417				131,676				44,227				190,320
Rent & occupancy costs			34,411				26,373				16,483				77,267
Consultants and professional services fees			1,783,082				140,795				261,359				2,185,236
Insurance			83,375				94,222				82,514				260,111
Warehousing expense			6,238				219,000				25,961				251,199
Regulatory expense			328,821				82,994				5,399				417,214
Travel expense			16,479				57,538				65,292				139,309
Research and development expense			-				411,896				9,013				420,909
Depreciation and amortization expense			38,936				-				-				38,936
Other segment items			152,951				273,239				13,405				439,595
Total operating expenses			3,273,061				2,547,796				926,668				6,747,525
Operating income (loss)			(3,273,061	)			634,979				(844,402	)			(3,482,484	)

		Six Months ending June 30, 2024
		Corporate				Dental				Medical				Grand Total
Product sales, net			-				4,076,189				26,420				4,102,609
Cost of products sold			-				1,010,955				4,347				1,015,302
Gross Margin			-				3,065,234				22,073				3,087,307
Salaries & employee benefits			557,899				754,413				398,810				1,711,122
Stock-based compensation expense			519,115				-				2,078				521,193
Royalty expense			-				209,321				1,321				210,642
Marketing			48,346				217,437				17,717				283,500
Rent & occupancy costs			35,799				24,486				15,304				75,589
Consultants and professional services fees			1,122,379				84,052				486,762				1,693,193
Insurance			203,882				44,913				33,598				282,393
Warehousing expense			6,154				226,703				19,872				252,729
Regulatory expense			237,817				5,063				6,332				249,212
Travel expense			27,626				49,214				47,154				123,994
Research and development expense			-				408,270				909				409,179
Depreciation and amortization expense			20,161				-				-				20,161
Other segment items			297,214				195,761				6,916				499,891
Total operating expenses			3,076,392				2,219,633				1,036,773				6,332,798
Operating income (loss)			(3,076,392	)			845,601				(1,014,700	)			(3,245,491	)

		June 30, 2025
		Corporate				Dental				Medical				Grand Total
Total Assets			2,010,665				5,653,581				386,584				8,050,830
			2,010,665				5,653,581				386,584				8,050,830

		December 31, 2024
		Corporate				Dental				Medical				Grand Total
Total Assets			3,992,825				5,359,734				444,513				9,797,072
			3,992,825				5,359,734				444,513				9,797,072

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration